Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Cue Biopharma, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 63 | 1 | 78 | +16 |
| Shares | 12.1M | 13.5K | 13.8M | +1.81M (+15.0%) |
| Value | $43.0M | $48.3K | $50.5M | +$7.56M (+17.6%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (29)
Institutions that held Cue Biopharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (13)
Institutions that held Cue Biopharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Prosight Management, LP | 1,151,855 | $4.11M |
| P.A.W. Capital Corp | 150,000 | $535.5K |
| Voss Capital, LLC | 125,000 | $446.3K |
| Parallax Volatility Advisers, L.P. | 75,000 | $267.8K |
| Cubist Systematic Strategies, LLC | 40,320 | $143.9K |
| Jane Street Group, LLC | 26,974 | $96.3K |
| Squarepoint Ops LLC | 20,233 | $72.2K |
| Simplex Trading, LLC | 11,586 | $41.0K |
| Group One Trading, L.P. | 1,578 | $5.63K |
| Point72 Middle East FZE | 646 | $2.31K |
| Accel Wealth Management | 318 | $1.14K |
| Johnson Midwest Financial, LLC | 300 | $1.07K |
| Advisory Services Network, LLC | 200 | $714 |
Not filed for Q2 2023 yet (1)
Institutions that held Cue Biopharma, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 13,528 | $48.3K |